Role and Purpose Sample Clauses

Role and Purpose. The Scientific Advisory Board shall provide advice to the ELIXIR Board and ELIXIR Director in relation to ELIXIR activities from a scientific perspective.

Role and Purpose. The Heads of Nodes Committee shall be composed of representatives of the ELIXIR Nodes and EMBL-EBI. The Heads of Nodes Committee shall give advice to the ELIXIR Board and Director in relation to ELIXIR activities. The ELIXIR Director shall consult the Heads of Nodes Committee to establish the Programme which he/she will submit to the ELIXIR Board.

Role and Purpose. Each such committee (i.e. the Joint Development Committee and Joint Commercialization Committee) shall be composed of an equal number of representatives from each Party with appropriate experience and expertise. Each such committee shall be a forum for information-sharing and discussion between the Parties and shall not have any decision-making authority, and shall meet [***] for [***] and [***] for [***] or at times and frequencies as otherwise mutually agreed by the Parties. Solely to the extent consistent with a Party’s reporting and information sharing obligations elsewhere in this Agreement, each Party will provide such information to the applicable committee as the other Party may reasonably request with respect to Development, Manufacture or Commercialization of Licensed Compounds and Licensed Products in the Field in its Applicable Territory and will keep such committee reasonably informed of such Party’s activities with respect to the Licensed Compounds and Licensed Products in the Applicable Territory.

Role and Purpose. Role and Purpose of this Agreement 2. This Agreement will allow for the extension and geographical expansion of the National Disability Insurance Scheme (NDIS) National Disability Insurance Agency (NDIA) trial site in WA. 3. This Agreement is a new schedule to the Intergovernmental Agreement IGA NDIS signed on 7 December 2012 and builds on Schedule G signed on 31 March 2014. 4. This Agreement should be read in conjunction with a number of the Annexes of the IGA NDIS being: a. Annex C: Portability Arrangements b. Annex D: Principles to Determine the Responsibilities of the NDIS and other Services Systems; and c. Annex E: Continuity of Support. 5. This Agreement builds on the Agreement between the Commonwealth and Western Australian Governments for disability reform in Western Australia signed on 5 August 2013.The Agreement provided for a two year trial of two service delivery models via: a. a National Partnership Agreement on Trial of My Way Sites, to test the WA NDIS My Way model delivered by the WA Disability Services Commission (DSC) under State legislation, with additional Commonwealth Government funding from 1 July 2014. The WA NDIS sites cover the Lower South West DSC region and the Cockburn/Kwinana DSC region; b. Schedule G to the Intergovernmental Agreement for the National Disability Insurance Scheme Launch (the IGA NDIS), to test the NDIS model delivered by the NDIA in the Perth Hills area under national governance arrangements set out in the National Disability Insurance Act 2013 (the NDIS Act 2013). 6. This Agreement provides for the: a. extension of the NDIA trial site in the Perth Hills area for 12 months until 30 June 2017; and b. expansion of the trial from 1 January 2017 into the Local Government Areas (LGAs) of Bayswater, Bassendean, Chittering, Toodyay, York and Northam (expansion sites), covering a total of 1,223 people by 30 June 2017. 7. The extension and expansion of the trial of the WA NDIS model delivered by the DSC is set out in the new National Partnership Agreement on Extension and Expansion of the Trial of WA NDIS Sites (the NPA). 8. The extension and expansion of the trial will allow for the assessment and comparison of the different approaches to disability services and help determine and inform the national roll-out of the NDIS in Western Australia and nationally. 9. Following the period of the extended and expanded WA NDIS trials, the phased state-wide roll out of the NDIS will commence in Western Australia on 1 July 2017, s...

Role and Purpose. The purpose of the Ministers’ Redress Scheme Governance Board (the Board) is to assist the proper, efficient and effective performance of the Scheme during its period of operation. The Board has decision-making powers in relation to proposed amendments to primary legislation, rules, policy guidelines and this Agreement. The Board will cease simultaneously with the Scheme, unless terminated earlier. The Commonwealth Minister is the Chairperson of the Board. The Board consists of the Commonwealth Minister and other state and territory ministers responsible for redress in participating jurisdictions (i.e. states that have referred power or adopted the law, and territories). Participating states and territories must nominate one Minister as the lead representative, that is, the Minister who is responsible for redress. A member of the Board may appoint a representative to act as a member of the Board in place of the member. Such appointment may be limited to a particular meeting(s) and may be revoked at any time. The acting member may exercise the voting rights of the member concerned. The Board will have the following functions: Discuss key issues relating to: implementation and operational matters (including review and evaluation activities); emerging policy, operational or communication issues; and matters relating to participation in the Scheme. Discuss and agree on proposed amendments to primary legislation, rules, policy guidelines and this Agreement. Manage cost risks. All Board members can bring forward proposals for amendments except those who have not declared participating government institutions. The Board will not consider or influence decisions made in relation to individual applications. In performing its functions, the Board must have regard to relevant analysis and advice. The Board, through the Commonwealth Minister, can seek the advice of the Roundtable to inform its decision-making. The Commonwealth Department responsible for operating the Scheme (currently the Department of Social Services) will provide secretariat support to the Board. The secretariat will be responsible for the provision of reports to the Board. This will include, for example, data about the number of applications, decisions, approved applications, and accepted offers of redress. Reports will also focus on redress outcomes including monetary and CPC payments made and/or the number of CPC services and direct personal responses delivered. The secretariat will also provide t...

Role and Purpose. The JSC shall (i) provide a forum for the discussion of the Parties’ activities under this Agreement and for sharing with Verastem the progress, results and other relevant information with respect to the Development and Commercialization by Licensee in the Field in the Territory; (ii) review, discuss and approve the overall strategy for the Exploitation of Licensed Products in the Field in the Territory; (iii) review, discuss and approve any amendments to the Development Plan in accordance with Section ‎4.2; (iv) review, discuss and approve the Commercialization Plan and amendments thereto; (v) establish and oversee the JPT and Working Groups as necessary or advisable to further the purpose of this Agreement; (vi) serve as a forum for Verastem to share the Global Strategy, the study plans and details for the Global Clinical Trials, and status, results and other relevant information in connection with the Global Clinical Trials and Verastem’s Exploitation of the Licensed Product in the Field outside the

Role and Purpose. For the first review, the independent panel of reviewers will investigate and provide advice, to COAG, on: progress made by the Parties in implementing the NPSI and the funding arrangements set out in this Agreement over the first two years of operation; whether jurisdictions are on-track to give effect to complete transition of funding arrangements set out in Part 5 and Schedule A by 31 December 2019; the appropriateness of the methodology and data inputs of the Commonwealth and State and Territory funding models; whether the education reforms under the NPSI are appropriate to achieve agreed outcomes; and any other agreed matters agreed between First Ministers of participating jurisdictions. For the second review, the relevant Standing Council will provide COAG with advice, for agreement, on the scope and focus of the review before 30 June 2018. At a minimum, the scope of the second review will examine: progress made by the Parties towards successful implementation of the NPSI and trajectory towards achievement of the 2025 targets , having regard to progress against targets, the national evidence base, emerging priorities and the link to funding; whether the education reforms under the NPSI are appropriate, effective and efficient; the SRS and State and Territory funding models’ accuracy and the appropriateness of their respective data inputs and methodology; and the conceptual adequacy and appropriateness of data sets and performance indicators . The reviews will give consideration to both government and non‑government sectors within participating jurisdictions. For each review, within one month of the completion of the review period, the independent review panel will provide a full report to COAG. Reports will be published on the COAG website following COAG consideration. In its reporting, the independent panel of reviewers will consider where recommendations might affect existing arrangements under this Agreement and Australian Education Act 2013.

Role and Purpose. The TanBIF National Committee will be the means by which the Participants will make collective decisions on all matters relating to TanBIF, which will then be put into effect by the TanBIF Secretariat.

Role and Purpose. The JCC shall (i) provide a forum for the discussion of the Parties’ activities under this Agreement and for sharing the progress, results and other relevant information with respect to Development and Commercialization by the Parties of Licensed Products in the Field; (ii) review, discuss and approve the overall strategy for the Exploitation of Licensed Products in the Field in the Territory; (iii) review, discuss and approve the Commercialization Plan and amendments thereto; and (iv) perform such other functions as expressly set forth in this Agreement or allocated to the JCC by the Parties’ written agreement. Each Party shall share information at the JCC in sufficient detail (i) to enable Verastem to assess Licensee’s compliance with Licensee’s Development and Commercialization obligations hereunder and enable Verastem to comply with Verastem’s obligations pursuant to [* * *] of the Infinity Agreement and (ii) to enable Licensee to comply with its Development and Commercialization obligations hereunder. For the sake of clarity, Verastem is under no obligation to share the confidential information of Third Party Licensees.

Role and Purpose. The JSC shall (i) provide a forum for the discussion of the Parties’ activities under this Agreement and for sharing with Verastem the progress, results and other relevant information with respect to the Development and Commercialization by Licensee in the Field in the Territory; (ii) draft, review and approve the Development Plan and any amendments thereto pursuant to Section 4.2, (iii) review, discuss and approve the overall strategy for the Exploitation of Licensed Products in the Field in the Territory; (iv) review, discuss and approve the Commercialization Plan and amendments thereto; (v) establish and oversee the JPT and Working Groups as necessary or advisable to further the purpose of this Agreement; (vi) approve the Clinical Trial design of Clinical Trials to be conducted in the Territory, in accordance with Verastem’s Global Clinical Trial program, and serve as a forum for Verastem to share the Global Strategy, the study plans and details for the Global Clinical Trials, and status, results and other relevant information in connection with the Global Clinical Trials and Verastem’s Exploitation of the Licensed Product in the Field outside the Territory; and (vii) perform such other functions as expressly set forth in this Agreement or allocated to the JSC by the Parties’ written agreement.